Owlet (OWLT) Net Income towards Common Stockholders (2020 - 2026)

Owlet's (OWLT) quarterly Net Income towards Common Stockholders came in at -$4.1 million in Q1 2026, down 336.96% year-on-year from $1.7 million in Q1 2025, and up 58.15% on a QoQ basis from -$9.9 million in Q4 2025.

Owlet (OWLT) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

Owlet (OWLT) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$4.1 million in Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 336.96% year-over-year to -$4.1 million in Q1 2026; TTM through Mar 2026 was -$48.6 million, a 179.48% decrease from a year earlier, with the FY2025 full-year figure at -$41.9 million, down 143.1% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$4.1 million, up from -$9.9 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for OWLT reached as high as $2.7 million in Q3 2025 and fell as low as -$37.2 million in Q2 2025.
  • Historically, Net Income towards Common Stockholders has averaged -$10.7 million across 5 years, with a median of -$9.7 million in 2024.
  • On a YoY basis, Net Income towards Common Stockholders climbed as much as 139.61% in 2025 and fell as far as 1286.54% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$19.5 million in 2022, then jumped by 57.85% to -$8.2 million in 2023, then declined by 17.8% to -$9.7 million in 2024, then slipped by 2.23% to -$9.9 million in 2025, then soared by 58.15% to -$4.1 million in 2026.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$4.1 million in Q1 2026, -$9.9 million in Q4 2025, and $2.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 183.83 Bn 176.54 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.96 Bn 126.08 Bn 3.81 Bn 745.00 Mn
3 Medtronic 108.62 Bn 99.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 68.62 Bn 67.16 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.35 Bn 44.67 Bn 1.29 Bn -
6 Dexcom 28.45 Bn 27.33 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 28.18 Bn 25.90 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.91 Bn 26.33 Bn - -
9 Koninklijke Philips 24.68 Bn 21.55 Bn 2.07 Bn 176.78 Mn
10 Owlet 145.72 Mn 104.71 Mn 12.24 Mn -4.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.14 Mn
Dec 31, 2025 -9.90 Mn
Sep 30, 2025 2.68 Mn
Jun 30, 2025 -37.19 Mn
Mar 31, 2025 1.75 Mn
Dec 31, 2024 -9.68 Mn
Sep 30, 2024 -6.76 Mn
Jun 30, 2024 -2.68 Mn
Mar 31, 2024 1.29 Mn
Dec 31, 2023 -8.22 Mn
Sep 30, 2023 -6.96 Mn
Jun 30, 2023 -9.79 Mn
Mar 31, 2023 -12.52 Mn
Dec 31, 2022 -19.50 Mn
Sep 30, 2022 -19.36 Mn
Jun 30, 2022 -11.72 Mn
Mar 31, 2022 -28.76 Mn
Dec 31, 2021 -24.06 Mn
Sep 30, 2021 -34.46 Mn
Jun 30, 2021 -5.34 Mn